The average one-year price target for Adc Therapeutics (NYSE:ADCT) has been revised to 8.77 / share. This is an increase of 9.79% from the prior estimate of 7.99 dated October 4, 2023. The price ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Here is how ADC Therapeutics SA (ADCT) and Biogen Inc. (BIIB) have performed compared to their sector so far this year.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

View ADC Therapeutics Ltd ADCT stock quote prices, financial information, real-time forecasts, and company news from CNN.

ADCs are a promising development in cancer treatment, targeting specific tumors with minimal side effects. ADCT's first drug, Zynlonta, was approved for third line treatment of lymphoma, but a halted ...

ADC Therapeutics has raised $200 million (€170 million), bringing its total haul up to $455 million. The antibody-drug conjugate (ADC) specialist will use the money to take its two lead hematological ...

ADC Therapeutics (ADCT) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.

BOSTON, SHANGHAI & LAUSANNE, Switzerland--(BUSINESS WIRE)--Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics SA (NYSE: ADCT), today announced the ...